Filed Pursuant to Rule 424(b)(3)
Relating to Registration Statement No. 333-13469
TITAN PHARMACEUTICALS, INC.
SUPPLEMENT DATED JULY 16, 1997
TO REGISTRATION STATEMENT DATED DECEMBER 2, 1996
This supplement should be read in conjunction with the Prospectus dated
December 2, 1996 contained in Registration Statement No. 333-13469 of Titan
Pharmaceuticals, Inc. a Delaware corporation (the "Company"), including the
exhibits thereto.
SELLING SECURITYHOLDERS
The following sets forth information regarding an additional Private
Placement Investor for which the Company has registered securities for resale to
the public.
<TABLE>
<CAPTION>
Number of Securities Maximum Number Number of Securities
Beneficially Owned of Securities Beneficially Owned
Name of Beneficial Owner Prior to Offering to be Sold After Offering
- ------------------------ ----------------- ---------- --------------
Shares(1) Warrants Shares Warrants Shares(1) Warrants
--------- -------- ------ -------- --------- --------
<S> <C> <C> <C> <C> <C> <C>
Edara Partnership 72,000 72,000 72,000 72,000 0 0
- -------------
(1) Does not include shares of Common Stock underlying the Warrants.
</TABLE>
